Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 108,645 of its own shares between July 6 and July 10 as part of its ongoing buyback program. The shares were acquired at an average price of €26.67, totaling approximately €2.9 million, bringing the company's total treasury holdings to 412,401 shares.
Key figures
- Total cost eur
- 2897722.65
- Treasury shares
- 412401
- Average price eur
- 26.67
- Shares repurchased
- 108645
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.